Niraparib with androgen receptor‑axis‑targeted therapy in patients
Blog - Latest News
You are here: Home1 / Niraparib With Androgen Receptor-Axis-Targeted Therapy In Patients With Metastatic Castration-Resistant Prostate Cancer: Safety And Pharmacokinetic Results From A Phase 1b Study (BEDIVERE)2 / Niraparib with androgen receptor‑axis‑targeted therapy in patients
Contact
Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572
Phone: (843) 839-1679
Fax: (843) 286-0119
Email:
info@curcmb.com
Recent Happenings
Our Affiliates
Leave a Reply
Want to join the discussion?Feel free to contribute!